ReviewCancer management and research2025

Pembrolizumab for the Treatment of Locally Advanced Cutaneous Squamous Cell Carcinoma: Patient Selection and Special Considerations.

Matthew Stewart et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.